**About Northeastern University** • The Northeastern University Pharmaceutical Industry Fellowships Program is a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates, preparing Fellows to meet evolving workforce needs across various sectors of the pharmaceutical industry.
• Fellows have the opportunity to work closely with innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly activities.
• Eidos, an affiliate of BridgeBio Pharma, Inc., is a biopharmaceutical company focused on discovering, creating, testing, and delivering transformative medicines for genetic diseases.
• Eidos specifically focuses on the treatment of ATTR-CM, and their product, Acoramidis (marketed as Attruby), received FDA approval in November 2024.
• Northeastern University offers a comprehensive benefits package for benefit-eligible employees.
• All qualified applicants are encouraged to apply and will receive consideration for employment without regard to race, religion, color, national origin, age, sex, sexual orientation, disability status, or any other characteristic protected by applicable law.
Jobs posted by BridgeBio Pharma
